Tradestie Institutional Equity Comparison Engine
MTNB vs CORT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CORT Overall Edge
CORT Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Corcept Therapeutics Inc. (CORT) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MTNB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus CORT at 13.0x Forward P/E and 11.5% operating margin (+64.0% YoY). In options structure, MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CORT sits in CONSOLIDATION (19th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CORT
MTNB N/M vs CORT 13.0x Fwd P/E
Growth & Margin Winner
CORT
Op Margin 0.0% vs 11.5% ยท YoY -100.0% vs +64.0%
Momentum & Technical Winner
CORT
1Y -31.4% vs -13.5% ยท 52W Pos 22% vs 37%
Options & Structure Winner
CORT
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (19th %ile IV)
MTNB
NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap
$979,904
1M Return
-46.7%
1Y Return
-31.35%
Forward P/E
N/M
Unified AI Score
54.6 / 100
HOLD
Tech 53.0
Fund 58.0
Flow 50.0
Mom 60.0
CORT
NASDAQ
Corcept Therapeutics Inc.
Pharmaceutical Preparations
$64.98
-4.15% 1D
Market Cap
$7.4B
1M Return
-44.12%
1Y Return
-13.49%
Forward P/E
13.0x
Unified AI Score
43.9 / 100
HOLD
Tech 25.0
Fund 56.0
Flow 69.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MTNB -31.35%
CORT -13.49%
Spread: +17.86 pp (CORT Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MTNB Revenue | CORT Revenue | MTNB Op. Margin | CORT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | $250M | -12230.9% | 35.6% | CORT |
| FY2019 | $0M | $310M | -21067.4% | 36.4% | CORT |
| FY2020 | $0M | $350M | -15288.4% | 36.2% | CORT |
| FY2021 | $0M | $370M | -74954.5% | 34.0% | CORT |
| FY2022 | $0M | $400M | -771.3% | 28.0% | CORT |
| FY2023 | $0M | $480M | -2168.4% | 22.2% | CORT |
| FY2024 | N/A | $680M | N/A | 20.3% | CORT |
| FY2025 | N/A | $760M | N/A | 5.9% | CORT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MTNB | CORT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $979,904 | $7.4B | Larger Scale | CORT |
| Trailing P/E Ratio Valuation | N/M | 51.0x | Lower Multiple | CORT |
| Forward P/E Ratio Valuation | N/M | 13.0x | Lower Multiple | CORT |
| Revenue Growth (YoY) Growth | -100.0% | +64.0% | Higher Growth | CORT |
| Operating Margin (TTM) Profitability | 0.0% | 11.5% | Higher Margin | CORT |
| Net Profit Margin Profitability | 0.0% | 16.8% | Higher Margin | CORT |
| Return on Equity (ROE) Capital Efficiency | -147.5% | 22.1% | Higher ROE | CORT |
| 52-Week Range Position Momentum | 22% ($0โ$3) | 37% ($29โ$126) | Stronger Trend | CORT |
| Beta / 30D Volatility Risk Regime | -7.20ฮฒ ยท 147% Vol | 1.62ฮฒ ยท 81% Vol | Lower Realized Risk | CORT |
| Unified Institutional Score Composite Signal | 54.6 / 100 (HOLD) | 43.9 / 100 (HOLD) | Higher Composite | MTNB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MTNB vs CORT Buy Guide
MTNB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CORT
CONSOLIDATION
112d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
19th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MTNB nor CORT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.